
David Browe
Examiner (ID: 15326, Phone: (571)270-1320 , Office: P/1617 )
| Most Active Art Unit | 1617 |
| Art Unit(s) | 1616, 1617 |
| Total Applications | 929 |
| Issued Applications | 188 |
| Pending Applications | 112 |
| Abandoned Applications | 644 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18003469
[patent_doc_number] => 20220362235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => PHARMACEUTICAL COMPOSITIONS OF CABOZANTINIB
[patent_app_type] => utility
[patent_app_number] => 17/866877
[patent_app_country] => US
[patent_app_date] => 2022-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18435
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17866877
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/866877 | PHARMACEUTICAL COMPOSITIONS OF CABOZANTINIB | Jul 17, 2022 | Abandoned |
Array
(
[id] => 18075900
[patent_doc_number] => 20220401512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING EPILEPSY, SEIZURES AND OTHER CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/850088
[patent_app_country] => US
[patent_app_date] => 2022-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13002
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 416
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17850088
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/850088 | COMPOSITIONS AND METHODS FOR TREATING EPILEPSY, SEIZURES AND OTHER CONDITIONS | Jun 26, 2022 | Abandoned |
Array
(
[id] => 17850459
[patent_doc_number] => 20220280500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => PHARMACEUTICAL COMPOSITIONS OF CABOZANTINIB
[patent_app_type] => utility
[patent_app_number] => 17/824518
[patent_app_country] => US
[patent_app_date] => 2022-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16794
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17824518
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/824518 | PHARMACEUTICAL COMPOSITIONS OF CABOZANTINIB | May 24, 2022 | Abandoned |
Array
(
[id] => 20334731
[patent_doc_number] => 20250338851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-06
[patent_title] => Boosted IPBC for Wet-State Bacterial Control
[patent_app_type] => utility
[patent_app_number] => 18/561936
[patent_app_country] => US
[patent_app_date] => 2022-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18561936
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/561936 | Boosted IPBC for Wet-State Bacterial Control | May 19, 2022 | Pending |
Array
(
[id] => 18056448
[patent_doc_number] => 20220387534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => ANTIOXIDANT AND ANTIMICROBIAL COMPOSITIONS AND METHODS OF USING THEM TO PROTECT SKIN OR TREAT OR PREVENT INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/745284
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54603
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17745284
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/745284 | ANTIOXIDANT AND ANTIMICROBIAL COMPOSITIONS AND METHODS OF USING THEM TO PROTECT SKIN OR TREAT OR PREVENT INFECTIONS | May 15, 2022 | Abandoned |
Array
(
[id] => 17805782
[patent_doc_number] => 20220257617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => COMPOSITIONS AND METHODS FOR KELOIDLESS HEALING
[patent_app_type] => utility
[patent_app_number] => 17/737929
[patent_app_country] => US
[patent_app_date] => 2022-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6188
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17737929
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/737929 | COMPOSITIONS AND METHODS FOR KELOIDLESS HEALING | May 4, 2022 | Abandoned |
Array
(
[id] => 17805855
[patent_doc_number] => 20220257690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => CONTROLLED-RELEASE AND STRATIFIED CYCLODEXTRIN INCLUSION COMPLEX VEHICLES
[patent_app_type] => utility
[patent_app_number] => 17/736386
[patent_app_country] => US
[patent_app_date] => 2022-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12220
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17736386
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/736386 | Controlled-release and stratified cyclodextrin inclusion complex vehicles | May 3, 2022 | Issued |
Array
(
[id] => 19316107
[patent_doc_number] => 20240237647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => SPINOSYN PESTICIDAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/558468
[patent_app_country] => US
[patent_app_date] => 2022-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13680
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18558468
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/558468 | SPINOSYN PESTICIDAL COMPOSITIONS | May 2, 2022 | Pending |
Array
(
[id] => 17944221
[patent_doc_number] => 20220331238
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => OIL-IN-WATER EMULSION OF MOMETASONE
[patent_app_type] => utility
[patent_app_number] => 17/732080
[patent_app_country] => US
[patent_app_date] => 2022-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6388
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17732080
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/732080 | OIL-IN-WATER EMULSION OF MOMETASONE | Apr 27, 2022 | Abandoned |
Array
(
[id] => 18265445
[patent_doc_number] => 20230086687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR
[patent_app_type] => utility
[patent_app_number] => 17/731920
[patent_app_country] => US
[patent_app_date] => 2022-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11373
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17731920
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/731920 | DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR | Apr 27, 2022 | Abandoned |
Array
(
[id] => 19215436
[patent_doc_number] => 20240180140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => INSECT CONTROL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/556532
[patent_app_country] => US
[patent_app_date] => 2022-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5050
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18556532
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/556532 | INSECT CONTROL COMPOSITION | Apr 19, 2022 | Pending |
Array
(
[id] => 17774161
[patent_doc_number] => 20220240510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => SURFACE-TREATING WOOD TO PREVENT DISCOLORATION
[patent_app_type] => utility
[patent_app_number] => 17/721909
[patent_app_country] => US
[patent_app_date] => 2022-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3721
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17721909
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/721909 | SURFACE-TREATING WOOD TO PREVENT DISCOLORATION | Apr 14, 2022 | Abandoned |
Array
(
[id] => 18691390
[patent_doc_number] => 20230321606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => HIGHLY STABLE LIPID BILAYER (HSLB) WITH BIOPOLYMER SCAFFOLD AS CYTOSKELETON AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/714634
[patent_app_country] => US
[patent_app_date] => 2022-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6938
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17714634
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/714634 | HIGHLY STABLE LIPID BILAYER (HSLB) WITH BIOPOLYMER SCAFFOLD AS CYTOSKELETON AND USE THEREOF | Apr 5, 2022 | Abandoned |
Array
(
[id] => 19975970
[patent_doc_number] => 12343426
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-01
[patent_title] => Therapeutic hydrogels
[patent_app_type] => utility
[patent_app_number] => 17/713596
[patent_app_country] => US
[patent_app_date] => 2022-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 0
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17713596
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/713596 | Therapeutic hydrogels | Apr 4, 2022 | Issued |
Array
(
[id] => 19279101
[patent_doc_number] => 20240215572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => ANTIMICROBIAL PARTICLE DISPERSION
[patent_app_type] => utility
[patent_app_number] => 18/558081
[patent_app_country] => US
[patent_app_date] => 2022-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8794
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18558081
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/558081 | ANTIMICROBIAL PARTICLE DISPERSION | Mar 24, 2022 | Pending |
Array
(
[id] => 17718893
[patent_doc_number] => 20220211612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => GEL BASE COMPOSITION FOR COMPOUNDING INTO A MUCOADHESIVE DELIVERY SYSTEM
[patent_app_type] => utility
[patent_app_number] => 17/703427
[patent_app_country] => US
[patent_app_date] => 2022-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19941
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17703427
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/703427 | GEL BASE COMPOSITION FOR COMPOUNDING INTO A MUCOADHESIVE DELIVERY SYSTEM | Mar 23, 2022 | Abandoned |
Array
(
[id] => 17851738
[patent_doc_number] => 20220281780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => SEEDING FORMULATION FOR WOODY PLANTS AND PRE-TREATMENT OF LAND SURFACES
[patent_app_type] => utility
[patent_app_number] => 17/699960
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4732
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17699960
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/699960 | SEEDING FORMULATION FOR WOODY PLANTS AND PRE-TREATMENT OF LAND SURFACES | Mar 20, 2022 | Abandoned |
Array
(
[id] => 17881041
[patent_doc_number] => 20220296518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => LIPID-BASED NANOPARTICLE DELIVERY SYSTEM FOR HYDROPHILIC CHARGED COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/697941
[patent_app_country] => US
[patent_app_date] => 2022-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7744
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17697941
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/697941 | LIPID-BASED NANOPARTICLE DELIVERY SYSTEM FOR HYDROPHILIC CHARGED COMPOUND | Mar 17, 2022 | Pending |
Array
(
[id] => 17776453
[patent_doc_number] => 20220242802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => CONCENTRATED LIQUID COMPOSITIONS OF UREASE INHIBITORS FOR NITROGEN SOURCES
[patent_app_type] => utility
[patent_app_number] => 17/678427
[patent_app_country] => US
[patent_app_date] => 2022-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43409
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17678427
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/678427 | Concentrated liquid compositions of urease inhibitors for nitrogen sources | Feb 22, 2022 | Issued |
Array
(
[id] => 19216136
[patent_doc_number] => 20240180840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => METHODS OF DESIGNING AN ORAL DRUG DOSAGE FORM BASED ON A TARGET PK PROFILE AND DOSAGE FORMS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/550432
[patent_app_country] => US
[patent_app_date] => 2022-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17134
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18550432
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/550432 | METHODS OF DESIGNING AN ORAL DRUG DOSAGE FORM BASED ON A TARGET PK PROFILE AND DOSAGE FORMS THEREOF | Feb 22, 2022 | Pending |